Actinium Pharmaceuticals, Inc. (ATNM)
R&D Expenses
$5.38M
Quarterly · Period ending: · USD
ATNM R&D Expenses
Latest reported$5.38Mperiod ending
Latest reported$5.38Mperiod ending
ATNM Quarterly R&D Expenses ($0.00 → $5.38M)
Quarterly R&D Expenses
High-resolution chart · PNG
ATNM r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 5,377,000 | |
| 4,201,000 | |
| 4,912,000 | |
| 4,248,000 | |
| 4,879,000 | |
| 7,700,000 | |
| 4,607,000 | |
| 9,572,000 | |
| 8,636,000 | |
| 6,419,000 | |
| 7,919,000 | |
| 11,422,000 | |
| 10,872,000 | |
| 7,849,000 | |
| 7,172,000 | |
| 6,550,000 | |
| 4,482,000 | |
| 4,232,000 | |
| 5,279,000 | |
| 4,708,000 | |
| 3,631,000 | |
| 4,276,000 | |
| 4,639,000 | |
| 3,788,000 | |
| 3,508,000 | |
| 4,151,000 | |
| 3,373,660 | |
| 4,830,000 | |
| 4,010,000 | |
| 4,336,000 | |
| 5,085,000 | |
| 4,221,000 | |
| 3,325,000 | |
| 4,463,000 | |
| 3,672,000 | |
| 4,957,000 | |
| 4,379,000 | |
| 4,504,000 | |
| 3,902,000 | |
| 5,686,000 | |
| 4,148,000 | |
| 3,765,000 | |
| 2,597,000 | |
| 2,828,000 | |
| 3,838,000 | |
| 4,049,000 | |
| 4,031,000 | |
| 3,773,000 | |
| 2,002,000 | |
| 2,461,000 | |
| 293,659 | |
| 778,232 | |
| 509,262 | |
| 1,086,000 | |
| 1,162,000 | |
| 1,677,000 | |
| 601,272 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |